All News

2064 articles, sorted by publication time.

Policy and Regulation · global

UK’s New Clinical Trial Law Takes Effect: Faster Review for Low-Risk Studies, Alongside Higher Transparency Obligations

The most extensive reform of clinical trial regulations in more than two decades creates fast-track pathways for low-risk research and certain amendments; the other side of the bargain is that public registration, results disclosure, and communication with participants are shifting from advocacy to legal obligations.

Biotech Industry · global

Enlivex Bets on RAIN Tokens, Potential Ninefold Share Increase Tests Its Identity as a Biotech Company

The clinical-stage company plans a $400 million private placement with the RAIN Foundation and retains the right to raise another $400 million; the transaction could substantially dilute existing shareholders, while the concentration of both funds and tokens within the same ecosystem puts drug development, corporate governance, and asset liquidity in the spotlight.

Biotechnology Industry · global

Veradermics Expands Commercial Team, Gets Early Start on Launch Preparations for Oral Hair-Loss Drug

From market intelligence and physician marketing to supply chain and legal affairs, Veradermics is building the commercial framework for extended-release oral minoxidil. However, the pivotal confirmatory trial has yet to report results, and the hiring activity signals launch preparation—not that the regulatory outcome is already assured.

Regenerative Medicine · us

From Skin Cells to Brain Transplantation: Two More Cohorts Complete Dosing With Personalized Cell Therapy for Parkinson’s Disease

A total of 15 people have received sasineprocel in the early-stage ASPIRO trial; the latest two cohorts are the first to use a cryopreserved formulation that can be thawed upon arrival and injected immediately, marking a major step in manufacturing and clinical distribution rather than a definitive conclusion on efficacy.

Health Technology · global

Clinical AI Is Moving Into the Exam Room, and Adoption Is Outpacing Validation Systems

From real-time prompts providing the basis for diagnosis and treatment during medical-record conversations to literature-based answers for physicians’ queries, specialized clinical AI systems are competing to become the gateway to decision-making. Yet usage rates, internal safety scores, and actual improvements in patient outcomes remain three different things.